Recruiting
Transplant rejection+1
RecruitingA Study of Belimumab to Help Identify Safe Kidney Transplant Matches in Patients with High Antibody Levels Against Donor Tissue Types
Registered drugNo placebo
A Study of Belimumab to Help Identify Safe Kidney Transplant Matches in Patients with High Antibody Levels Against Donor Tissue Types
Registered drugNo placebo
- Disease:Transplant rejectionAnti-HLA antibody test positive
- Substances:Belimumab
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Belimumab
- Sponsor:Leids Universitair Medisch Centrum (LUMC)